期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 63, 期 12, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01111-19
关键词
KPC; ceftazidime-avibactam; Klebsiella pneumoniae
资金
- University of Fribourg, Switzerland
- Swiss National Science Foundation [FNS-31003A_163432]
A novel KPC variant, KPC-41, was identified in a Klebsielia pneumoniae clinical isolate from Switzerland. This beta-lactamase possessed a 3-amino-acid insertion (Pro-Asn-Lys) located between amino acids 269 and 270 compared to the KPC-3 amino acid sequence. Cloning and expression of the bla(KPC-41) gene in Escherichia coli, followed by determination of MIC values and kinetic parameters, showed that KPC-41, compared to those of KPC-3, has an increased affinity to ceftazidime and a decreased sensitivity to avibactam, leading to resistance to ceftazidime-avibactam once produced in K. pneumoniae. Furthermore, KPC-41 exhibited a drastic decrease of its carbapenemase activity. This report highlights that a diversity of KPC variants conferring resistance to ceftazidime-avibactam already circulate in Europe.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据